ScholarIQanswers from OpenAlex & ORCID
Kimberly Cooper
ResearcherPublications, citations & collaboration network
Kimberly Cooper is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kimberly Cooper have?
ScholarIQindexed works
Kimberly Cooper has 35 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kimberly Cooper have?
ScholarIQcitation count
Kimberly Cooper has 3,133 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kimberly Cooper?
ScholarIQh-index
Kimberly Cooper has an h-index of 18 in OpenAlex.
What is the i10-index of Kimberly Cooper?
ScholarIQi10-index
Kimberly Cooper has an i10-index of 22 in OpenAlex.
What is the OpenAlex record for Kimberly Cooper?
ScholarIQopenalex
The OpenAlex for Kimberly Cooper is on the source record.
What are the most-cited papers on Kimberly Cooper?
ScholarIQmost cited works
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova, Ella Daly, Madhukar H. Trivedi, Kimberly Cooper, Rosanne Lane, Pilar Lim, Christine Mazzucco, David Hough, Michael E. Thase, Richard C. Shelton, Patricio Molero, Eduard Vieta, Malek Bajbouj, Husseini K. Manji, Wayne C. Drevets, Jaskaran Singh
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
Ella Daly, Jaskaran Singh, Maggie Fedgchin, Kimberly Cooper, Pilar Lim, Richard C. Shelton, Michael E. Thase, Andrew Winokur, Luc Van Nueten, Husseini K. Manji, Wayne C. Drevets
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran Singh, Maggie Fedgchin, Ella Daly, Peter de Boer, Kimberly Cooper, Pilar Lim, Christine Pinter, James W. Murrough, Gerard Sanacora, Richard C. Shelton, Benji T. Kurian, Andrew Winokur, Maurizio Fava, Husseini K. Manji, Wayne C. Drevets, Luc Van Nueten
Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder
Timothy E. Wilens, Keith McBurnett, Oscar G. Bukstein, James J. McGough, Laurence L. Greenhill, Marc Lerner, Mark A. Stein, C. Keith Conners, John C. Duby, Jeffrey H. Newcorn, C. Everett Bailey, Christopher J. Kratochvil, Daniel L. Coury, Charles D. Casat, Mary Joan C. Denisco, Patricia Halstead, Leslie Bloom, Brenda Zimmerman, Joan Gu, Kimberly Cooper, Joseph M. Lynch
Does Prolonged Therapy With a Long-Acting Stimulant Suppress Growth in Children With ADHD?
Thomas Spencer, Stephen V. Faraone, Joseph Biederman, Marc Lerner, Kimberly Cooper, Brenda Zimmerman